Previous 10 | Next 10 |
NEW YORK, NY / ACCESSWIRE / December 12, 2019 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: William Lyon Homes ( WLH ) related to its...
NEW YORK, NY / ACCESSWIRE / December 11, 2019 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Instructure, Inc (NYSE: INST ) related to...
On Dec. 9, pharmaceutical giant Sanofi (NASDAQ: SNY) said it's buying immuno-oncology company Synthorx (NASDAQ: THOR) for $2.5 billion to boost its cancer and autoimmune program. Considering the performance of Sanofi's businesses, the pipeline Synthorx brings to the ...
Major benchmarks drifted lower Monday as uncertainty over a trade deal continued to weigh on the market. The Dow Jones Industrial Average (DJINDICES: ^DJI) and the S&P 500 (SNPINDEX: ^GSPC) closed near session lows. Data source: Yahoo! Finance. As for individual...
The Internet Pounces on their Marketing and Peloton Stock Suffers Last week the Twitterverse stormed and condemned Peloton ( PTON ). It has been the target of satirical YouTube videos; Aviation Gin even created a YouTube ad spoofing Peloton and drafting off of PTON’s misery. Has PTO...
Gainers: Synthorx (NASDAQ: THOR ) +170% . More news on: Synthorx, Inc., ArQule, Inc., Forty Seven, Inc., Stocks on the move, Read more ...
NEW YORK, Dec. 09, 2019 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Synthorx, Inc. (NASDAQ: THOR) to Sanofi for $68.00 per share is fair to Synthorx shareholders. On behalf of Synthorx shareholders, Halper Sadeh LLP may seek ...
Shares of the clinical-stage biotech Synthorx (NASDAQ: THOR) jumped by an eye-popping 169% right out of the gate Monday morning. What's behind this enormous spike? Synthorx's stock is on fire today in response to an all-cash buyout agreement with French pharma giant Sanofi (NASDAQ: SNY...
DENVER, Colo., December 9, 2019- (24/7MarketNews via COMTEX) Venture Market News for December 9, 2019. Market Trend As the US-China trade talks may continue to try to take up all the air in the room, biotech M&A activity is quietly picking up, with two high premium acquisitions in the spce...
Synthorx (NASDAQ: THOR ) +169% on being acquired by Sanofi. More news on: Synthorx, Inc., XBiotech Inc., ArQule, Inc., Stocks on the move, Read more ...
News, Short Squeeze, Breakout and More Instantly...
The U.S. Securities and Exchange Commission (SEC) got a win in its case against Thor Technologies for an unauthorized sale of $2.6 million in&...
AMC Theatres (NYSE: AMC) has reported domestic and global success on its busiest weekend of 2022 so far from Thursday July 7th through Sunday July 10th. This was led by the opening weekend of Thor: Love and Thunder as the box office was propelled by several summer blockb...
Thor Industries (NYSE: THOR ) , a recreational vehicle maker, reported better-than-expected quarterly earnings Wednesday amid high demand for its products. The manufacturer reported earnings of USD6.32 per share, compared to the expected USD...